EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Point-of-Care HbA1c in Clinical Practice: Caveats and Considerations for Optimal Use

David B Sacks iD, M Sue Kirkman iD, Randie R Little iD

Diabetes Care · 01.07.2024 · 47 (7) · 1104-1110

DOI: 10.2337/dci23-0040 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Diabetes Care, online erschienen am 29.03.2024. Verfasst von David B Sacks und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, Clinical Center, National Institutes of Health, Bethesda, MD. Hauptthemen laut MEDLINE: Glycated Hemoglobin, Point-of-Care Systems. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, NIH HHS, NIH Clinical Center.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hemoglobin A1c (A1C) is widely used for the diagnosis and management of diabetes. Accurate measurement of A1C is necessary for optimal clinical value. Assay standardization has markedly improved the accuracy and consistency of A1C testing. Devices to measure A1C at point of care (POC) are commercially available, allowing rapid results when the patient is seen. In this review, we describe how standardization of A1C testing was achieved, leading to high-quality results in clinical laboratories. We address the use of POC A1C testing in clinical situations and summarize the advantages and disadvantages of POC A1C testing. We emphasize the importance of considering the limitations of these devices and following correct testing procedures to ensure that accurate A1C results are obtained for optimal care of patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Glycated HemoglobinPoint-of-Care SystemsHumansDiabetes Mellitus

Substanzen

Glycated Hemoglobin

Autor:innen und Institutionen

  • Department of Laboratory Medicine, Clinical Center, National Institutes of Health, Bethesda, MD.
  • Division of Endocrinology and Metabolism, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC.
  • Department of Pathology and Anatomical Sciences, University of Missouri School of Medicine, Columbia, MO.

ORCID-Profile: David B Sacks, M Sue Kirkman, Randie R Little

Förderung

  • NIDDK NIH HHS
  • NIH HHS
  • NIH Clinical Center
  • National Institutes of Health

Zitieren

APA

Sacks, D. B., Kirkman, M. S., & Little, R. R. (2024). Point-of-Care HbA1c in Clinical Practice: Caveats and Considerations for Optimal Use. Diabetes Care, 47(7), 1104-1110. https://doi.org/10.2337/dci23-0040

Vancouver

Sacks DB, Kirkman MS, Little RR. Point-of-Care HbA1c in Clinical Practice: Caveats and Considerations for Optimal Use. Diabetes Care. 2024;47(7):1104-1110. doi:10.2337/dci23-0040

BibTeX
@article{Sacks2024,
  author = {Sacks, David B and Kirkman, M Sue and Little, Randie R},
  title = {Point-of-Care HbA1c in Clinical Practice: Caveats and Considerations for Optimal Use},
  journal = {Diabetes Care},
  year = {2024},
  volume = {47},
  number = {7},
  pages = {1104--1110},
  doi = {10.2337/dci23-0040}
}
Kostenlos starten →